Kentucky's Attorney General announced on Thursday that the state is suing the pharmacy chain Walgreens for allegedly exacerbating the "man-made" opioid crisis, by playing a dual role in in the supply chain as both the distributor and dispenser. Read the full article on NPR here.
Carmen Rodríguez Santiago counts herself lucky to have any water service at home. But eight months after Hurricane Maria, the 52-year-old security guard said the faucets in her cream-and-pink-colored house still run dry every two to three days, and the water, when it returns, is flecked with sediment. Read the full article on KHN here.
Barbara L. McAneny, MD, an oncologist from Albuquerque, has been sworn in as the 173rd President of the American Medical Association (AMA). She will focus her tenure on the AMA’s three strategic arcs: attacking the dysfunction in health care by removing obstacles and barriers that interfere with patient care; reimagining medical education, training, and lifelong
Democrats are seizing on the Trump administration’s push in court to overturn ObamaCare’s protections for people with pre-existing conditions, hoping to leverage the issue ahead of November’s midterm elections as some Republicans rush to distance themselves from the move. Read the full article on The Hill here.
Skyrocketing specialty drug costs were a primary reason behind Cigna’s decision to purchase Express Scripts, even though the insurer has an in-house pharmacy benefit manager, Cigna’s chief financial officer said on Tuesday. Read the full article on Fierce Healthcare here.
The recent wave of mergers could truly shake up the health care marketplace. CVS purchasing Aetna? Cigna acquiring Express Scripts? What will happen when a health care company can meet almost all of a patient’s needs within one organization? Read the full article on Morning Consult here.
The federal government has the authority to modify or eliminate the rebates pharmacy benefit managers get from drug makers on behalf of patients in Medicare prescription drug plans, Health and Human Services Secretary Alex Azar said Tuesday, the clearest indication yet that the administration might exercise that power. Read the full article on Stat News
Allowing Medicare to negotiate directly with drugmakers to set prices could backfire and force the program to pay even higher prices for drugs, HHS Secretary Alex Azar told senators on Tuesday.In a Senate Committee on Health, Education Labor & Pensions (HELP) hearing, Democratic lawmakers suggested drafting a bill allowing the HHS secretary to tell drugmakers
Hospitals on Tuesday urged Congress to pass a newly introduced bill to strengthen the 340B drug discount program. Under the Stretching Entity Resources for Vulnerable (SERV) Communities Act introduced by Rep. Doris Matsui (D-Calif.), the HHS secretary must audit 340B providers and drug manufacturers. Read the full article on Modern Healthcare here.